Editas Medicine Stock Market Value
| EDIT Stock | USD 5.55 0.06 1.07% |
| Symbol | Editas |
Editas Medicine Price To Book Ratio
Is Editas Medicine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Editas Medicine. If investors know Editas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Editas Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.02) | Revenue Per Share 1.028 | Quarterly Revenue Growth 8.187 | Return On Assets (0.21) | Return On Equity (0.43) |
The market value of Editas Medicine is measured differently than its book value, which is the value of Editas that is recorded on the company's balance sheet. Investors also form their own opinion of Editas Medicine's value that differs from its market value or its book value, called intrinsic value, which is Editas Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Editas Medicine's market value can be influenced by many factors that don't directly affect Editas Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Editas Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Editas Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Editas Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Editas Medicine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Editas Medicine's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Editas Medicine.
| 10/22/2023 |
| 04/19/2024 |
If you would invest 0.00 in Editas Medicine on October 22, 2023 and sell it all today you would earn a total of 0.00 from holding Editas Medicine or generate 0.0% return on investment in Editas Medicine over 180 days. Editas Medicine is related to or competes with Beam TherapeuticsInc, Crispr Therapeutics, Caribou Biosciences, Verve Therapeutics, Intellia Therapeutics, Prime Medicine, and Vertex Pharmaceuticals. Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines t... More
Editas Medicine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Editas Medicine's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Editas Medicine upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 34.07 | |||
| Value At Risk | (6.30) | |||
| Potential Upside | 7.03 |
Editas Medicine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Editas Medicine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Editas Medicine's standard deviation. In reality, there are many statistical measures that can use Editas Medicine historical prices to predict the future Editas Medicine's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.76) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.21) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Editas Medicine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Editas Medicine Backtested Returns
Editas Medicine secures Sharpe Ratio (or Efficiency) of -0.1, which denotes the company had a -0.1% return per unit of risk over the last 3 months. Editas Medicine exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Editas Medicine's Standard Deviation of 5.03, variance of 25.27, and Mean Deviation of 3.32 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.79, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Editas Medicine will likely underperform. Editas Medicine has an expected return of -0.52%. Please make sure to confirm Editas Medicine maximum drawdown, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Editas Medicine performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
Editas Medicine has average predictability. Overlapping area represents the amount of predictability between Editas Medicine time series from 22nd of October 2023 to 20th of January 2024 and 20th of January 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Editas Medicine price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Editas Medicine price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | -0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 1.16 |
Editas Medicine lagged returns against current returns
Autocorrelation, which is Editas Medicine stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Editas Medicine's stock expected returns. We can calculate the autocorrelation of Editas Medicine returns to help us make a trade decision. For example, suppose you find that Editas Medicine has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Editas Medicine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Editas Medicine stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Editas Medicine stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Editas Medicine stock over time.
Current vs Lagged Prices |
| Timeline |
Editas Medicine Lagged Returns
When evaluating Editas Medicine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Editas Medicine stock have on its future price. Editas Medicine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Editas Medicine autocorrelation shows the relationship between Editas Medicine stock current value and its past values and can show if there is a momentum factor associated with investing in Editas Medicine.
Regressed Prices |
| Timeline |
Pair Trading with Editas Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Editas Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will appreciate offsetting losses from the drop in the long position's value.Moving together with Editas Stock
| 0.77 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.62 | KZR | Kezar Life Sciences Financial Report 9th of May 2024 | PairCorr |
Moving against Editas Stock
| 0.61 | MRKR | Marker Therapeutics | PairCorr |
The ability to find closely correlated positions to Editas Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Editas Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Editas Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Editas Medicine to buy it.
The correlation of Editas Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Editas Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Editas Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Editas Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Editas Medicine Correlation, Editas Medicine Volatility and Editas Medicine Alpha and Beta module to complement your research on Editas Medicine. For more information on how to buy Editas Stock please use our How to Invest in Editas Medicine guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Editas Stock analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance |
Editas Medicine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.